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Host Genetics of Infectious Diseases:
Old and New Approaches Converge
The increasing interest in infectious disease
genetics over the last 5 years reflects several
trends in the biomedical sciences, not least the
explosion of knowledge in human genomics.
However, infectious disease genetics is not a new
field; some of the largest twin studies were
performed more than 50 years ago, and the first
malaria resistance gene was identified soon
afterwards. The current excitement reflects a
recent increase in power in several of the
approaches being used to map and identify the
genes responsible for variable susceptibility to
many major infectious diseases. Four distinct
approaches have been used to identify infectious
disease susceptibility and resistance genes; these
approaches may now be converging.
Approaches
Candidate Genes
The most popular type of study in the host
genetics of infectious disease compares the allele
or genotype frequencies of so-called candidate
genes in clinical cases with matched controls.
Candidate genes are selected on the basis of their
function and likely relevance to the disease of
interest and on the possession of one or more
genetic variants (1). This approach has been very
successful. Starting with the globin genes and
glucose-6-phosphate deficiency, several candi-
date genes were found in case-control studies to
be associated with malaria resistance. A different
approach associated the Duffy blood group with
Plasmodium vivax malaria resistance many
years before the blood group was known to be a
chemokine receptor.  In many infectious diseases,
HLA variation has been studied, and several
associations have been established. The early
associations between HLA-DR2 and susceptibil-
ity to leprosy and tuberculosis (TB) in India have
been reconfirmed in recent years.  Most recently,
chemokine receptors and a deletion variant of
CCR5 have been found to affect both risk for HIV-
1 infection and rate of progression to AIDS.
Despite these successes, problems remain
with the candidate gene approach. Most sample
sizes have been adequate to detect only very
strong associations; however, less marked
associations may be more common. Matching
controls to cases may be problematic and has led
to the recent trend for family-based association
studies in other types of polygenic disease.
Frequent geographic heterogeneity in HLA
associations has complicated the interpretation
of studies of these important genes. Finally, the
limited effects observed in most studies suggest
that this approach might be missing some other
genes with more major effects. Nonetheless, with
more promising candidate polymorphisms ap-
pearing each month, the popularity of this
approach will likely increase.
Mouse Genetics
A quite different approach to finding human
infectious disease resistance and susceptibility
genes has been identifying relevant murine
genes. The relative ease of mapping susceptibility
genes in inbred strains of mice has led to the
mapping of numerous named loci in mice by
linkage analysis. In some cases, such as with the
murine Mx influenza resistance locus, the gene
has actually been identified (2). Far more genes
have been mapped in this way than have been
identified. A well-studied exception is the murine
Nramp1 gene that was positionally cloned on
chromosome 1 (3) after this locus was shown to
influence susceptibility to certain leishmanial,
mycobacterial and salmonella infections in mice.
Another important recent approach has been the
use of gene knockout mice to determine whether
particular genes affect susceptibility to various
infectious diseases.
A difficulty with the mouse genetics approach
is that a gene identified in mouse studies may
turn out to lack polymorphism in humans. This
difficulty is particularly relevant for artificially
generated knockout mice; inactivating mutations
of key genes may be too deleterious to humans.
Such mutations, like mutations of the interferon-
gamma receptor gene (4), may, however, turn up
rarely in immunodeficient children. However,
even mutations that are polymorphic in inbred
mouse strains, such as the Nramp1 variant, may
be nonpolymorphic in wild mouse populations.
Given the differences in selection pressure that
mice and humans have been exposed to over tens
of millions of years, the major susceptibility
genes in the two species are unlikely to be the
same. Another difficulty is, of course, the extent
to which a murine model may mimic human
infectious disease. The human malarias, for696 Emerging Infectious Diseases Vol. 4, No. 4, OctoberDecember 1998
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example, cannot be studied in mice.
Complex Segregation Analysis
Complex segregation analysis models the
transmission of the disease in multicase families
and compares the likelihood of different ways of
inheriting the disease. Several parameters may
be optimized, including the contribution of a
potential single major gene, polygenic and
environmental components, allele frequencies,
and dominance. The remarkable result is the
regularity with which a single major gene is
reported. For example, a single major gene has
thus been implicated in leprosy, schistosomiasis,
TB, and even malaria (regulating parasite
densities) (5). Even allowing for some publication
bias, these remarkable results are surprising in
view of the highly polygenic nature of infectious
disease susceptibility suggested by candidate
gene analysis. A major gene, as proposed in these
models, would need both a high frequency and
very high odds ratio to account for a substantial
proportion of the overall genetic effect. One
explanation might be that such single major
genes remain to be identified in these and
perhaps many other infectious diseases.
The usefulness of complex segregation
analysis is difficult to assess because in no case
has the single major gene proposal been
confirmed by mapping and identifying such a
gene. However, this difficulty may be ending as
genome scanning technology is increasingly
applied to infectious diseases.
Human Genomewide Analysis
The most recent approach applied to human
infectious diseases is mapping and subsequently
identifying major genes affecting susceptibility
or resistance through genomewide scans. This
approach entails an initial linkage analysis in
large numbers of multicase families, which is
followed by association study analysis for gene
identification. Typically, a few hundred
microsatellite markers search for evidence of
increased sharing of parental alleles identical by
descent in affected sibling pairs. This nonpara-
metric approach does not require information on
how the disease was inherited, which is almost
always unknown. However, in schistosomiasis
the results of complex segregation analysis have
been used in a parametric, or model-based,
analysis to map a susceptibility gene to
chromosome 5 in a small number of Brazilian
families (6), as reviewed by Abel and Dessein in
this issue. The degree to which this genomewide
approach can be used to map major susceptibility
genes in reasonable numbers of families remains
uncertain. However, the genes with the largest
effects are those that can be mapped with most
power and may be of greatest interest.
The main limitation of a genomewide
linkage scan in polygenic infectious diseases is
that its power is lower than that of association
studies. Recruiting the required large numbers
of clinically well-defined multicase families
may require multicenter collaborations. Tech-
nical advances may make genomewide associa-
tion studies feasible, which would remove the
need for the use of multicase families, although
the requirement for large numbers of cases
would remain.
Approach Convergence
Until recently, these various genetic ap-
proaches were typically pursued by different
research groups with relatively little synergistic
interaction. The major candidate genes studied in
humans were different from those mapped in
mice, and none of the associations found
appeared strong enough to fit the single major
genes being proposed by complex segregation
analysis. However, researchers working on the
Nramp1 gene in mice suggested that the human
homologue,  NRAMP1, could correspond to a
major mycobacterial susceptibility gene sug-
gested by segregation analysis in humans. This
theory has now become testable with the
identification of numerous polymorphisms in
NRAMP1. A clear association emerges between
variation in this gene and TB susceptibility, at
least in a West African population (7). Thus a
gene identified through whole genome analysis in
mice, potentially the major gene suggested by
complex segregation analysis, is associated with
susceptibility when investigated as a candidate
gene in a human case-control study. The separate
approaches have converged, we hope for the first
of many meetings.
However, little in complex disease genetics is
simple. The effect observed in  Gambia is
different from BCG susceptibility in mice in that
in human TB, susceptibility appears dominant
(7), while in mice it is recessive. Also, the effect in
humans, though highly statistically significant,
is relatively modest, perhaps a few percentage
points of the overall genetic component of697 Vol. 4, No. 4, OctoberDecember 1998 Emerging Infectious Diseases
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susceptibility. Although not the elusive major
gene, this effect is well worth investigating for
the light it may throw on mechanisms of disease
susceptibility. As other candidate genes are
identified from mouse studies, they may add to
the long list of candidate genes available for
human association studies. Meanwhile, the hunt
for elusive major susceptibility genes continues.
Ongoing genome scans should soon help
determine whether these genes really exist in
particular infectious diseases; if they do, their
mechanisms of action as well as the forces
underlying their evolutionary maintenance
should be of great interest.
Adrian V.S. Hill
University of Oxford, Oxford, United Kingdom
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